tm
Seeing Is Believing
tm
Seeing Is Believing
Healthcare - Sector
RCUS is currently covered by 10 analysts with an average price target of $30.91. This is a potential upside of $21.88 (242.3%) from yesterday's end of day stock price of $9.03.
Arcus Biosciences's activity chart (see below) currently has 78 price targets and 91 ratings on display. The stock rating distribution of RCUS is 84.21% BUY and 15.79% HOLD.
Analysts average stock forecasts to be materialized ratio is 24.29% with an average time for these price targets to be met of 194.29 days.
Highest price target for RCUS is $46, Lowest price target is $14, average price target is $35.
Most recent stock forecast was given by TERENCE FLYNN from MORGAN STANLEY on 09-May-2025. First documented stock forecast 09-Apr-2018.
Currently out of the existing stock ratings of RCUS, 32 are a BUY (84.21%), 6 are a HOLD (15.79%).
Analyst name
Rating
Current price target
Potential Upside
Previous price target
Date
Price targets met ratio
Average potential upside
Average Time (Days) For PT To Be Met
Performance score
Buy
$22
$12.98 (143.90%)
$25
18 days ago
(09-May-2025)
0/7 (0%)
$13.72 (165.70%)
Buy
$14
$4.98 (55.21%)
$29
1 months 4 days ago
(23-Apr-2025)
3/8 (37.5%)
$5.89 (72.63%)
108
Hold
$24
$14.98 (166.08%)
$18
3 months 1 days ago
(26-Feb-2025)
0/4 (0%)
$13.76 (134.38%)
Hold
$17
$7.98 (88.47%)
$23
3 months 8 days ago
(19-Feb-2025)
2/4 (50%)
$5.9 (53.15%)
14
Buy
$46
$36.98 (409.98%)
$38
7 months 3 days ago
(24-Oct-2024)
2/12 (16.67%)
$28.17 (157.99%)
294
What is RCUS (Arcus Biosciences) average time for price targets to be met?
Which analyst has the current highest performing score on RCUS (Arcus Biosciences) with a proven track record?
Which analyst has the most public recommendations on RCUS (Arcus Biosciences)?
Which analyst is the currently most bullish on RCUS (Arcus Biosciences)?
Which analyst is the currently most reserved on RCUS (Arcus Biosciences)?
